Shank‑associated RH domain interactor signaling in tumorigenesis (Review)-Reference-Cited by-同舟云学术

Shank‑associated RH domain interactor signaling in tumorigenesis (Review)

Published:2020-07-09 Issue:3 Volume:20 Page:2579-2586
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Zeng Chong¹,Xiong Dan²,Zhang Ketao³,Yao Jie¹

Affiliation:

1. Medical Research Center, Shunde Hospital, Southern Medical University, The First People's Hospital of Shunde, Foshan, Guangdong 528308, P.R. China

2. Department of Hematology, Shunde Hospital, Southern Medical University, The First People's Hospital of Shunde, Foshan, Guangdong 528308, P.R. China

3. Department of Hepatobiliary Surgery, Shunde Hospital, Southern Medical University, The First People's Hospital of Shunde, Foshan, Guangdong 528308, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR/Cas9-mediated knock-in cells of the late-onset Alzheimer’s disease-risk variant, SHARPIN G186R, reveal reduced NF-κB pathway and accelerated Aβ secretion;Journal of Human Genetics;2024-02-13

2. SHARPIN promotes cell proliferation of cholangiocarcinoma and inhibits ferroptosis via p53/ SLC7A11 / GPX4 signaling;Cancer Science;2022-09-08

3. PTEN as a target in melanoma;Journal of Clinical Pathology;2022-05-09

4. Advances in the Structural and Physiological Functions of SHARPIN;Frontiers in Immunology;2022-04-25

5. Platelet SHARPIN regulates platelet adhesion and inflammatory responses through associations with αIIbβ3 and LUBAC;Blood Advances;2022-04-21